Yoonjin Cho

600 total citations
16 papers, 480 citations indexed

About

Yoonjin Cho is a scholar working on Genetics, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Yoonjin Cho has authored 16 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Pathology and Forensic Medicine and 3 papers in Physiology. Recurrent topics in Yoonjin Cho's work include Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Lysosomal Storage Disorders Research (3 papers). Yoonjin Cho is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Lysosomal Storage Disorders Research (3 papers). Yoonjin Cho collaborates with scholars based in United States, South Korea and Poland. Yoonjin Cho's co-authors include Steven Coutré, Ian W. Flinn, Jennifer R. Brown, Sissy Peterman, Stephen E. Spurgeon, Wayne R. Godfrey, Nina D. Wagner‐Johnston, Richard R. Furman, Brad S. Kahl and John C. Byrd and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Yoonjin Cho

15 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoonjin Cho United States 8 378 327 151 141 98 16 480
Evgenii A. Osmanov Russia 6 207 0.5× 352 1.1× 110 0.7× 316 2.2× 50 0.5× 22 493
Arnau Montraveta Spain 12 236 0.6× 182 0.6× 281 1.9× 103 0.7× 96 1.0× 17 492
Stefan Norin Sweden 9 216 0.6× 185 0.6× 127 0.8× 131 0.9× 112 1.1× 28 393
Alice Mohr United States 7 413 1.1× 402 1.2× 156 1.0× 187 1.3× 139 1.4× 14 627
Shih‐Shih Chen United States 12 321 0.8× 214 0.7× 126 0.8× 118 0.8× 236 2.4× 41 494
Thomas M. Jahn United States 11 636 1.7× 437 1.3× 236 1.6× 96 0.7× 219 2.2× 22 743
Simon Rule United Kingdom 7 189 0.5× 321 1.0× 62 0.4× 242 1.7× 31 0.3× 12 390
Brian Munneke United States 7 161 0.4× 219 0.7× 61 0.4× 170 1.2× 54 0.6× 13 337
Josephine L. Klitgaard United States 7 171 0.5× 97 0.3× 178 1.2× 133 0.9× 111 1.1× 11 426
Lixia Pei United States 10 144 0.4× 224 0.7× 176 1.2× 312 2.2× 38 0.4× 27 476

Countries citing papers authored by Yoonjin Cho

Since Specialization
Citations

This map shows the geographic impact of Yoonjin Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoonjin Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoonjin Cho more than expected).

Fields of papers citing papers by Yoonjin Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoonjin Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoonjin Cho. The network helps show where Yoonjin Cho may publish in the future.

Co-authorship network of co-authors of Yoonjin Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Yoonjin Cho. A scholar is included among the top collaborators of Yoonjin Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoonjin Cho. Yoonjin Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cho, Yoonjin, et al.. (2024). Membrane association of active genes organizes the chloroplast nucleoid structure. Proceedings of the National Academy of Sciences. 121(28). e2309244121–e2309244121. 1 indexed citations
2.
Cho, Yoonjin, et al.. (2024). The association between tooth brushing during lunchtime and obesity in South Korean adolescents. Scientific Reports. 14(1). 20730–20730.
3.
Wang, Raymond, Nina Movsesyan, Shih‐hsin Kan, et al.. (2024). First in-human, intracisternal dosing of RGX-111, an investigational AAV gene therapy, for a 21-month-old child with mucopolysaccharidosis type I (MPS I): 3.5 year follow-up. Molecular Genetics and Metabolism. 141(2). 108070–108070. 1 indexed citations
4.
Cho, Yoonjin, et al.. (2022). Beyond the normative data: Understanding the Mullen Scales of Early Learning (MSEL). Molecular Genetics and Metabolism. 135(2). S31–S31. 1 indexed citations
5.
Harmatz, Paul, Maria L. Escolar, Can Fıçıcıoğlu, et al.. (2022). RGX-121 gene therapy for the treatment of severe mucopolysaccharidosis type II (MPS II): Interim analysis of data from the first in-human study. Molecular Genetics and Metabolism. 135(2). S54–S54. 2 indexed citations
6.
Névoret, Marie-Laure, Maria L. Escolar, Can Fıçıcıoğlu, et al.. (2021). RGX-121 gene therapy for severe mucopolysaccharidosis type II (MPS II): Interim results of an ongoing first in human trial. Molecular Genetics and Metabolism. 132(2). S76–S76. 3 indexed citations
7.
O’Brien, Karen M., et al.. (2020). The Good Mothering Expectations Scale: An International Instrument Development Study. The Counseling Psychologist. 48(2). 162–190. 8 indexed citations
8.
Coutré, Steven, John P. Leonard, Christopher R. Flowers, et al.. (2015). Idelalisib monotherapy and durable responses in patients with relapsed or refractory Waldenstroms Macroglobulinemia (WM).. Journal of Clinical Oncology. 33(15_suppl). 8532–8532. 4 indexed citations
9.
Coutré, Steven, Jacqueline C. Barrientos, Jennifer R. Brown, et al.. (2015). Safety of idelalisib in B-cell malignancies: Integrated analysis of eight clinical trials.. Journal of Clinical Oncology. 33(15_suppl). e18030–e18030. 14 indexed citations
10.
Jones, Jeffrey A., Małgorzata Wach, Tadeusz Robak, et al.. (2015). Results of a phase III randomized, controlled study evaluating the efficacy and safety of idelalisib (IDELA) in combination with ofatumumab (OFA) for previously treated chronic lymphocytic leukemia (CLL).. Journal of Clinical Oncology. 33(15_suppl). 7023–7023. 19 indexed citations
11.
Flinn, Ian W., Brad S. Kahl, John P. Leonard, et al.. (2014). Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma. Blood. 123(22). 3406–3413. 167 indexed citations
12.
13.
Zelenetz, Andrew D., Nicole Lamanna, Thomas J. Kipps, et al.. (2014). A Phase 2 Study of Idelalisib Monotherapy in Previously Untreated Patients ≥65 Years with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). Blood. 124(21). 1986–1986. 24 indexed citations
14.
Kahl, Brad S., Stephen E. Spurgeon, Richard R. Furman, et al.. (2014). A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL). Blood. 123(22). 3398–3405. 199 indexed citations
15.
Cho, Hyojin, et al.. (2013). A Qualitative study on the meaning of work and experiences of career decision process of university students. 32(3). 675–699. 3 indexed citations
16.
Benson, Don M., Brad S. Kahl, Richard R. Furman, et al.. (2013). Final results of a phase I study of idelalisib, a selective inhibitor of PI3Kδ, in patients with relapsed or refractory indolent non-Hodgkin lymphoma (iNHL).. Journal of Clinical Oncology. 31(15_suppl). 8526–8526. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evgenii A. Osmanov Breakdown of academic impact, for papers by Arnau Montraveta Breakdown of academic impact, for papers by Stefan Norin Breakdown of academic impact, for papers by Alice Mohr Breakdown of academic impact, for papers by Shih‐Shih Chen Breakdown of academic impact, for papers by Thomas M. Jahn Breakdown of academic impact, for papers by Simon Rule Breakdown of academic impact, for papers by Brian Munneke Breakdown of academic impact, for papers by Josephine L. Klitgaard Breakdown of academic impact, for papers by Lixia Pei
Rankless by CCL
2026